Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb Perspect Biol. 2016;8:a006072.
Li X, Egervari G, Wang Y, Berger SL, Lu Z. Regulation of chromatin and gene expression by metabolic enzymes and metabolites. Nat Rev Mol Cell Biol. 2018;19:563–78.
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–33.
Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657–69.
Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635–49.
Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669–80.
O’Malley J, Kumar R, Inigo J, Yadava N, Chandra D. Mitochondrial stress response and cancer. Trends Cancer. 2020;6:688–701.
Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12:21–35.
Jones ME. Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annu Rev Biochem. 1980;49:253–79.
Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994;140:1–22.
Weber G. Ordered biochemical program of gene expression in cancer cells. Biochemistry (Mosc). 2001;66:1164–73.
Unger MM, Wahl J, Ushmorov A, Buechele B, Simmet T, Debatin KM, et al. Enriching suicide gene bearing tumor cells for an increased bystander effect. Cancer Gene Ther. 2007;14:30–38.
Fairbanks LD, Bofill M, Ruckemann K, Simmonds HA. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J Biol Chem. 1995;270:29682–9.
Okesli-Armlovich A, Gupta A, Jimenez M, Auld D, Liu Q, Bassik MC, et al. Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening. Bioorg Med Chem Lett. 2019;29:2559–64.
Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10:671–84.
Spratlin J, Sangha R, Glubrecht D, Dabbagh L, Young JD, Dumontet C, et al. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res. 2004;10:6956–61.
Gaidano V, Houshmand M, Vitale N, Carra G, Morotti A, Tenace V, et al. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia. Cancers (Basel). 2021;13:1003.
Peters GJ, Kraal I, Pinedo HM. In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine. Br J Cancer. 1992;65:229–33.
Cysyk RL, Malinowski N, Marquez V, Zaharevitz D, August EM, Moyer JD. Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo. Biochem Pharmacol. 1995;49:203–7.
Lane AN, Fan TW. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015;43:2466–85.
Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A. Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol. 2001;59:1181–6.
Zhou Q, Jiang H, Zhang J, Yu W, Zhou Z, Huang P, et al. Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway. Cancer Manag Res. 2018;10:6339–55.
Cai J, Sun X, Guo H, Qu X, Huang H, Yu C, et al. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis. 2020;9:103.
Cong X, Lu C, Huang X, Yang D, Cui X, Cai J, et al. Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell proliferation. Hum Pathol. 2014;45:1370–8.
Liu X, Ding Z, Liu Y, Zhang J, Liu F, Wang X, et al. Glycinamide ribonucleotide formyl transferase is frequently overexpressed in glioma and critically regulates the proliferation of glioma cells. Pathol Res Pract. 2014;210:256–63.
Zhang JM, Jiang C, Ye W, Luo R, Chen HF. Allosteric pathways in tetrahydrofolate sensing riboswitch with dynamics correlation network. Mol Biosyst. 2016;13:156–64.
Loong JH, Wong TL, Tong M, Sharma R, Zhou L, Ng KY, et al. Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma. J Clin Invest. 2021;131:e143377.
Huang Y, Li SR, Gao YJ, Zhu YH, Zhang XF. Novel gene signatures promote epithelial-mesenchymal transition (EMT) in glucose deprivation-Based microenvironment to predict recurrence-free survival in hepatocellular carcinoma. J Oncol. 2023;2023. 6114976.
Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Invest. 2021;131:e144703.
Nwosu ZC, Ward MH, Sajjakulnukit P, Poudel P, Ragulan C, Kasperek S, et al. Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature. 2023;618:151–8.
Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan GE. Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J. 2001;20:2160–70.
Manieri W, Moore ME, Soellner MB, Tsang P, Caperelli CA. Human glycinamide ribonucleotide transformylase: active site mutants as mechanistic probes. Biochemistry. 2007;46:156–63.
Knox AJ, Graham C, Bleskan J, Brodsky G, Patterson D. Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis. Gene. 2009;429:23–30.
Qian X, Li X, Tan L, Lee JH, Xia Y, Cai Q, et al. Conversion of PRPS Hexamer to Monomer by AMPK-Mediated Phosphorylation Inhibits Nucleotide Synthesis in Response to Energy Stress. Cancer Discov. 2018;8:94–107.
Welin M, Grossmann JG, Flodin S, Nyman T, Stenmark P, Tresaugues L, et al. Structural studies of tri-functional human GART. Nucleic Acids Res. 2010;38:7308–19.
Field MS, Kamynina E, Chon J, Stover PJ. Nuclear folate metabolism. Annu Rev Nutr. 2018;38:219–43.
Noguchi H, Prem veer Reddy G, Pardee AB. Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell. 1983;32:443–51.
Prem veer Reddy G, Pardee AB. Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci USA. 1980;77:3312–6.
Butler P, Pascheto I, Lizzi M, St-Onge R, Lanner C, Guo B, et al. RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cells. Sci Rep. 2023;13:1711.
Chen L, Ducker GS, Lu W, Teng X, Rabinowitz JD. An LC-MS chemical derivatization method for the measurement of five different one-carbon states of cellular tetrahydrofolate. Anal Bioanal Chem. 2017;409:5955–64.
Zhao Q, Zheng K, Ma C, Li J, Zhuo L, Huang W, et al. PTPS facilitates compartmentalized LTBP1 S-nitrosylation and promotes tumor Growth under hypoxia. Mol Cell. 2020;77:95–107 e105.
Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211–D1217.
Chen T, Ma J, Liu Y, Chen Z, Xiao N, Lu Y, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50:D1522–D1527.
Wang T, Yu Q, Li J, Hu B, Zhao Q, Ma C, et al. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency. Nat Cell Biol. 2017;19:833–43.
Lee JH, Liu R, Li J, Wang Y, Tan L, Li XJ, et al. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Mol Cell. 2018;70:197–210 e197.
Jakkula P, Qureshi R, Iqbal A, Sagurthi SR, Qureshi IA. Leishmania donovani PP2C: Kinetics, structural attributes and in vitro immune response. Mol Biochem Parasitol. 2018;223:37–49.
Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013;339:1323–8.
